Press release
Gene therapy Treatment Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration, Companies by DelveInsight | Candel Therapeutics, SillaJen Biotherapeutics, Wuhan Binhui Biotechnology, Virogin Biotech,
Gene therapy Treatment Pipeline
Key Takeaways from the Gene Therapy Competitive Landscape Report
• DelveInsight's Gene Therapy report depicts a robust space with 250+ active players working to develop 300+ pipeline therapies for Gene Therapy treatment.
• The leading companies working in the Gene Therapy Market include Candel Therapeutics, SillaJen Biotherapeutics, Wuhan Binhui Biotechnology, Virogin Biotech, Replimune, Istari Oncology, Immvira Pharma, Lokon Pharma, ORCA Therapeutics, Beijing SyngenTech, Tasly Pharmaceuticals, Turnstone Biologics, BioInvent, Transgene, Elicera Therapeutics, Orgenesis, Virttu Biologics, Imugene, Astellas Pharma, Mustang Bio, Virogin Biotech, Memgen, Replimune, Immvira Pharma, PsiOxus Therapeutics, VCN Biosciences, Sorrento Therapeutics, Calidi Biotherapeutics, Replimune, TILT Biotherapeutics, DNAtrix, and others.
• Promising Gene Therapy Therapies in the various stages of development include ABECMA, ADSTILADRIN, ALLOCOR, BREYANZI, CARVYKTI, CLEVECORD, Ducord, HPC Cord Blood, GINTUIT and others.
• December 2023: Sangamo Therapeutics announced a study of Phase 1 & 2 clinical trials for ST-920. This is the first in human treatment with ST-920, a recombinant AAV2/6 vector encoding the cDNA for human a-Gal A. The purpose of this study is to evaluate the safety and tolerability of ascending doses of ST-920. ST-920 aims to provide stable, long-term production of α-Gal A at therapeutic levels in subjects with Fabry disease. The constant production of α-Gal A in humans should, importantly, enable reduction and potentially clearance of Fabry disease substrates Gb3 and lyso-Gb3.
• December 2023: Regenxbio Inc. announced a study of Phase 1 & 2 clinical trials for RGX-202. RGX-202 is a gene therapy designed to deliver a transgene for a novel microdystrophin that includes functional elements of naturally-occurring dystrophin including the C-Terminal (CT) domain. This is a multicenter, open-label dose evaluation clinical study to assess the safety, tolerability and clinical efficacy of a one-time intravenous (IV) dose of RGX-202 in participants with Duchenne.
Request a sample and discover the recent advances in Gene Therapy @ Gene Therapy Competitive Landscape Report- https://www.delveinsight.com/sample-request/gene-therapy-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
The Gene Therapy report provides in-depth commercial assessment of drugs that have been included, which comprises collaboration, agreement, licensing and acquisition - deals values trends. The sub-segmentation is described in the Gene Therapy report which provide company-company collaboration (licensing/partnering), company academic collaboration and acquisition analysis in tabulated form.
Gene Therapy Overview
Gene therapy is a technique that uses a gene(s) to treat, prevent or cure a disease or medical disorder. Often, gene therapy works by adding new copies of a gene that is broken, or by replacing a defective or missing gene in a patient's cells with a healthy version of that gene. Both inherited genetic diseases (e.g., hemophiliaand sickle cell disease) and acquired disorders (e.g., leukemia) have been treated with gene therapy.
Find out more about Gene Therapy Analytical Perspective: In-depth Commercial Assessment @ Gene Therapy Collaboration Analysis by Companies- https://www.delveinsight.com/sample-request/gene-therapy-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Gene Therapy Companies and Therapies
• Candel Therapeutics: CAN-2409
• CRISPR Therapeutics: CTX001
• TILT Biotherapeutics: TILT-123
• Akamis Bio: NG-347
• And Many Others.
Gene Therapy Competitive Landscape
The Gene Therapy report comprises of comparative assessment of Companies (by therapy, development stage, and technology).
Gene Therapy Pipeline Report Assessment
• Gene Therapy Company Analysis
• Gene Therapy Therapeutic Assessment
• Gene Therapy Pipeline Assessment
• Gene Therapy Inactive drugs assessment
• Gene Therapy Unmet Needs
Learn more about the emerging Gene Therapy Competitive Landscape @ Gene Therapy Market Drivers and Barriers, Unmet Needs- https://www.delveinsight.com/sample-request/gene-therapy-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Scope of the Gene Therapy Report
• Coverage- Global
• Gene Therapy Therapeutics Assessment: Product Type, Stage and Product Type, Route of Administration, Molecule Type
Gene Therapy Companies- Candel Therapeutics, SillaJen Biotherapeutics, Wuhan Binhui Biotechnology, Virogin Biotech, Replimune, Istari Oncology, Immvira Pharma, Lokon Pharma, ORCA Therapeutics, Beijing SyngenTech, Tasly Pharmaceuticals, Turnstone Biologics, BioInvent, Transgene, Elicera Therapeutics, Orgenesis, Virttu Biologics, Imugene, Astellas Pharma, Mustang Bio, Virogin Biotech, Memgen, Replimune, Immvira Pharma, PsiOxus Therapeutics, VCN Biosciences, Sorrento Therapeutics, Calidi Biotherapeutics, Replimune, TILT Biotherapeutics, DNAtrix, and others.
Gene Therapy Therapies- ABECMA, ADSTILADRIN, ALLOCOR, BREYANZI, CARVYKTI, CLEVECORD, Ducord, HPC Cord Blood, GINTUIT and others.
Dive deep into rich insights for new drugs for Gene Therapy Product Developmental Activities, Visit @ Gene Therapy Research and Development Activities- https://www.delveinsight.com/sample-request/gene-therapy-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Content
Introduction
Executive Summary
Gene Therapy: Overview
Gene Therapy -Analytical Perspective: In-depth Commercial Assessment
Competitive Landscape
Therapeutic Assessment
Gene Therapy: Company and Product Profiles (Marketed Therapies)
Juno Therapeutics, Inc./Bristol-Myers Squibb
BREYANZI
Gene Therapy: Company and Product Profiles (Pipeline Therapies)
Late Stage Products (Phase III)
Candel Therapeutics
CAN-2409
Drug profiles in the detailed report…..
Mid Stage Products (Phase II)
Company Name
Product Name
Drug profiles in the detailed report…..
Early Stage Products (Phase I)
TILT Biotherapeutics
TILT-123
Drug profiles in the detailed report…..
Preclinical and Discovery Stage Products
Company Name
Product Name
Drug profiles in the detailed report…..
Inactive Products
Gene Therapy- Unmet needs
Gene Therapy - Market drivers and barriers
Appendix
For further information on the Gene Therapy Report @ Gene Therapy Preclinical and Discovery Stage Products- https://www.delveinsight.com/sample-request/gene-therapy-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Trending Reports:
• Acute Heart Failure Ahf Market: https://www.delveinsight.com/report-store/acute-heart-failure-ahf-market
• Alstrom Syndrome Market: https://www.delveinsight.com/report-store/alstrom-syndrome-market
• Biliary Tract Carcinoma Market: https://www.delveinsight.com/report-store/biliary-tract-cancers-btcs-market
• Chronic Plaque Psoriasis Market: https://www.delveinsight.com/report-store/chronic-plaque-psoriasis-market
• Neurofibromatosis 2 Market: https://www.delveinsight.com/report-store/neurofibromatosis-2-market
• Penicillinbinding Proteins Market: https://www.delveinsight.com/report-store/penicillin-binding-proteins-market
• Acute On Chronic Liver Failure Aclf Market: https://www.delveinsight.com/infographics/acute-on-chronic-liver-failure-aclf-market
• Age-related Macular Degeneration Market: https://www.delveinsight.com/report-store/age-related-macular-degeneration-amd-market
• Central Retinal Venous Occulsion Market: https://www.delveinsight.com/report-store/retinal-vein-occlusion-market
• Cervical Cancer Market Size: https://www.delveinsight.com/report-store/cervical-cancer-market
• Community-acquired Bacterial Pneumonia Market: https://www.delveinsight.com/report-store/community-acquired-bacterial-pneumonia-cabp-market
• Cutaneous T-cell Lymphoma Market: https://www.delveinsight.com/infographics/cutaneous-t-cell-lymphoma-ctcl-market
• Idiopathic Membranous Nephropathy Market: https://www.delveinsight.com/report-store/idiopathic-membranous-nephropathy-imn-market
• Wet-age Related Macular Degeneration Market: https://www.delveinsight.com/report-store/age-related-macular-degeneration-amd-market
• Clbp Market: https://www.delveinsight.com/report-store/chronic-lower-back-pain-clbp-market
• Corneal Endothelial Dystrophy Market: https://www.delveinsight.com/report-store/corneal-endothelial-dystrophy-market
• Androgenetic Alopecia Market: https://www.delveinsight.com/report-store/androgenetic-alopecia-market
• Interbody Cages Market: https://www.delveinsight.com/report-store/interbody-cages-market
• Lymphocytopenia Market: https://www.delveinsight.com/report-store/lymphocytopenia-market
• Refractory Angina Market: https://www.delveinsight.com/report-store/refractory-angina-market
• Stable Angina Market: https://www.delveinsight.com/report-store/angina-angina-pectoris-market
• Thrombocytopenia Market: https://www.delveinsight.com/report-store/thrombocytopenia-market
• Bacteremia Market: https://www.delveinsight.com/report-store/staphylococcus-aureus-bacteremia-market
• Achondroplasia Market: https://www.delveinsight.com/report-store/achondroplasia-market
• Beta Thalassemia Market: https://www.delveinsight.com/report-store/beta-thalassemia-market
• Acute Pharyngitis Market: https://www.delveinsight.com/report-store/acute-pharyngitis-market
• Catheter-related Bloodstream Infections Market: https://www.delveinsight.com/report-store/catheter-related-bloodstream-infection-market
• Chronic Hepatitis Delta Virus Market: https://www.delveinsight.com/infographics/hepatitis-d-market
• Heavy Metal Poisoning Market: https://www.delveinsight.com/report-store/heavy-metal-poisoning-market
• Hepatorenal Syndrome Market: https://www.delveinsight.com/report-store/hepatorenal-syndrome-market
• Hypoparathyroidism Market: https://www.delveinsight.com/report-store/hypoparathyroidism-market
• Ventricular Dysfunction Market: https://www.delveinsight.com/report-store/ventricular-dysfunction-market
• Chronic Obstructive Pulmonary Disease Copd Market: https://www.delveinsight.com/report-store/chronic-obstructive-pulmonary-disease-copd-market
• Chronic Pruritus Market: https://www.delveinsight.com/report-store/chronic-pruritus-market
• Atypical Teratoid Rhabdoid Tumors Market: https://www.delveinsight.com/report-store/atypical-teratoid-rhabdoid-tumors-market
• Hereditary Spastic Paraplegias Market: https://www.delveinsight.com/report-store/hereditary-spastic-paraplegias-market
• Advanced Renal Cell Carcinoma Market: https://www.delveinsight.com/report-store/advanced-renal-cell-carcinoma-rcc-market
• Familial Primary Pulmonary Hypertension Market: https://www.delveinsight.com/sample-request/familial-primary-pulmonary-hypertension-market
• Healthcare Pipeline Analysis: https://www.delveinsight.com/consulting/pipeline-assessment-services
• Optic Neuritis Market: https://www.delveinsight.com/report-store/optic-neuritis-market
• Parkinson's Disease Market: https://www.delveinsight.com/report-store/parkinsons-disease-market-size-analysis-treatment
• Post Traumatic Stress Disorder Market: https://www.delveinsight.com/report-store/post-traumatic-stress-disorder-ptsd-market
• Spasticity Market: https://www.delveinsight.com/report-store/spasticity-market
• Vitamin A Deficiency Market: https://www.delveinsight.com/report-store/vitamin-a-deficiency-market
• X Linked Hypophosphatemia Market: https://www.delveinsight.com/report-store/x-linked-hypophosphatemia-market
• Becker Muscular Dystrophy Market: https://www.delveinsight.com/report-store/becker-muscular-dystrophy-market
• Wegener S Granulomatosis/granulomatosis With Polyangiitis Market: https://www.delveinsight.com/report-store/wegeners-granulomatosis-market
• Artificial Lung Devices Market: https://www.delveinsight.com/report-store/artificial-lung-devices-pipeline-insight-and-competitive-landscape
• Diabetic Foot Ulcers Dfus Market: https://www.delveinsight.com/infographics/diabetic-foot-ulcers-dfus-market
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/asco-conference-coverage
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gene therapy Treatment Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration, Companies by DelveInsight | Candel Therapeutics, SillaJen Biotherapeutics, Wuhan Binhui Biotechnology, Virogin Biotech, here
News-ID: 3611918 • Views: …
More Releases from DelveInsight Business Research
Sarcoidosis Treatment Market 2032: FDA Approval, Clinical Trials, Prevalence, Th …
DelveInsight's "Sarcoidosis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Sarcoidosis, historical and forecasted epidemiology as well as the Sarcoidosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Sarcoidosis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Sarcoidosis Market Forecast
https://www.delveinsight.com/sample-request/sarcoidosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some of the key facts of the Sarcoidosis Market Report:
•…
Chronic Spontaneous Urticaria Treatment Market 2034: FDA Approval, Clinical Tria …
DelveInsight's "Chronic Spontaneous Urticaria Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Chronic Spontaneous Urticaria, historical and forecasted epidemiology as well as the Chronic Spontaneous Urticaria market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Chronic Spontaneous Urticaria market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Chronic Spontaneous Urticaria Market…
Chronic Lower Back Pain Treatment Market 2032: FDA Approval, Clinical Trials, Ma …
(Albany, USA) DelveInsight's "Chronic Lower Back Pain Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Chronic Lower Back Pain, historical and forecasted epidemiology as well as the Chronic Lower Back Pain market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Chronic Lower Back Pain market outlook, drug uptake, treatment scenario and epidemiology trends,…
Non-Small Cell Lung Cancer (NSCLC) Clinical Trials 2024: EMA, PDMA, FDA Approval …
(Albany, USA) DelveInsight's, "Non-Small-Cell Lung Cancer Pipeline Insight 2024" report provides comprehensive insights about 135+ Non-Small Cell Lung Cancer Companies and 150+ pipeline drugs in the Non-Small-Cell Lung cancer (NSCLC) pipeline landscape. It covers the Non-Small Cell Lung Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Non-Small Cell Lung Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It…
More Releases for Gene
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…
Gene Therapy Market, by Gene Therapy Type Germline Gene Therapy and Somatic Gene …
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with…
Gene Editing Market : A Market Study On Gene Editing And Cancer Therapy Techniqu …
Global Gene Editing Market
Precision Business Insights (PBI) in its report titled “Global Gene Editing Market : Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2027” assesses the market performance over 2018-2027. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.
Gene editing or Genome editing is…
Direct-to-consumer Genetic Testing Market: Top Players - Gene By Gene, MyHeritag …
Latest industry research report on: Global and United States Direct-to-consumer Genetic Testing Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
This report studies the Direct-to-consumer Genetic Testing market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Direct-to-consumer Genetic Testing market by product…
